Senolytics in Clinical Trials: Clearing Senescent Cells to Reverse Frailty and Idiopathic Pulmonary Fibrosis
Senolytics, drugs designed to clear senescent "zombie" cells, are showing promising results in clinical trials for age-r...
Read More →Senolytics, drugs designed to clear senescent "zombie" cells, are showing promising results in clinical trials for age-r...
Read More →Medical researchers are developing a universal influenza vaccine using mRNA and nanoparticle platforms to target the con...
Read More →Artificial intelligence is revitalizing antibiotic discovery by identifying novel molecular scaffolds and designing new ...
Read More →Medical researchers have successfully transplanted 10-gene edited pig kidneys into human recipients, overcoming the hist...
Read More →Verve Therapeutics' in vivo CRISPR base editing program, VERVE-102, utilizes lipid nanoparticles to permanently disable ...
Read More →Landmark trials like SELECT and FLOW have proven that GLP-1 agonists offer profound cardiovascular and renal protection,...
Read More →mRNA-4157/V940, a personalized neoantigen therapy developed by Moderna and Merck, has demonstrated a 44% reduction in re...
Read More →The p-tau217 blood biomarker test has revolutionized Alzheimer’s diagnosis, offering over 90% accuracy and replacing c...
Read More →AI healthcare breakthroughs in 2026 include Örebro University's 97% accurate dementia detection via EEG, AI-designed mo...
Read More →Global regulators are cracking down on AI-generated harmful content, with the EU banning "nudifier" apps, Australia enfo...
Read More →In response to AI-driven cyber threats, the US has signed an Executive Order streamlining model reviews and centralizing...
Read More →The Technology Innovation Institute's Falcon-H1R 7B shatters the "bigger is better" AI paradigm, outperforming models se...
Read More →